Open access
Open access
Powered by Google Translator Translator

All Posts

RCT: Among children with protracted bacterial bronchitis, a 4-week course of amoxicillin–clavulanate is not better than a 2-week course in achieving clinical cure by 28 days.

31 May, 2021 | 08:02h | UTC

Duration of amoxicillin-clavulanate for protracted bacterial bronchitis in children (DACS): a multi-centre, double blind, randomised controlled trial – The Lancet Respiratory Medicine

Commentary: Four weeks of antibiotics for kids’ chronic cough no better than 2, study finds – CIDRAP

 

Commentary on Twitter

 


Observational study suggests ceftriaxone is similarly effective to benzylpenicillin for the treatment of neurosyphilis, potentially decreasing the length of hospital stay (mean 13.8 days vs. 8.9 days).

31 May, 2021 | 08:06h | UTC

Ceftriaxone compared with benzylpenicillin in the treatment of neurosyphilis in France: a retrospective multicentre study – The Lancet Infectious Diseases (link to abstract – $ for full-text)

 


Academic bullying is too often ignored. Here are some targets’ stories.

31 May, 2021 | 07:59h | UTC

Academic bullying is too often ignored. Here are some targets’ stories – Science (a few articles per month are free)

 


Lab study found CoronaVac serum neutralization efficiency was significantly decreased against B.1.526, P.1, and B1.351 SARS-CoV-2 variants.

28 May, 2021 | 08:26h | UTC

Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac – The Lancet Infectious Diseases

 


COLCORONA RCT: Colchicine for community-treated patients with COVID-19 – findings suggest it may lower death and hospital admission rates, but further studies are required.

28 May, 2021 | 08:27h | UTC

Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial – The Lancet Respiratory Medicine

Invited Commentary: Exploiting an early immunological window of opportunity in COVID-19 – The Lancet Respiratory Medicine

 


WHO COVAX Joint Statement: Call to action to equip COVAX to deliver 2 billion doses in 2021.

28 May, 2021 | 08:28h | UTC

COVAX Joint Statement: Call to action to equip COVAX to deliver 2 billion doses in 2021 – World Health Organization

 

Commentary on Twitter (thread – click for more)

 


The global burden of smoking tobacco and attributable disease in 204 countries and territories – “In the absence of intervention, the annual toll of 7.69 million deaths and 200 million disability-adjusted life-years attributable to smoking will increase over the coming decades”.

28 May, 2021 | 08:19h | UTC

Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019 – The Lancet

News Release: The Lancet & The Lancet Public Health: Latest global data finds nearly 8 million deaths from smoking in 2019, and 90% of new smokers addicted by age 25 – Institute for Health Metrics and Evaluation

Related studies: Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019 – The Lancet Public Health AND Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and initiation among young people in 204 countries and territories, 1990–2019 – The Lancet Public Health

 


RCT: Pfizer-BioNTech Covid-19 vaccine shows 100% efficacy in adolescents – mainly transient mild-to-moderate reactogenicity was frequently observed, such as injection-site pain (in 79 to 86% of participants), fatigue (in 60 to 66%), and headache (in 55 to 65%).

28 May, 2021 | 08:24h | UTC

Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents – New England Journal of Medicine

Related: [Press release – not published yet] Pfizer-BioNTech vaccine 100% effective against Covid-19 in adolescents

 

Commentary on Twitter

 


Covid-19: Pfizer-BioNTech vaccine is “likely” responsible for deaths of some elderly patients, Norwegian review finds.

28 May, 2021 | 08:22h | UTC

Covid-19: Pfizer-BioNTech vaccine is “likely” responsible for deaths of some elderly patients, Norwegian review finds – The BMJ

 

Commentary on Twitter

 


Advance Care Planning for people with dementia: recognizing moral dilemmas faced by physicians.

28 May, 2021 | 08:14h | UTC

Advance Care Planning for people with dementia: recognising moral dilemmas faced by physicians – The Mental Elf

Original study: Which moral barriers and facilitators do physicians encounter in advance care planning conversations about the end of life of persons with dementia? A meta-review of systematic reviews and primary studies – BMJ Open

 


EULAR recommendations for intra-articular therapies.

28 May, 2021 | 08:16h | UTC

EULAR recommendations for intra-articular therapies – Annals of Rheumatic Diseases

 


Viewpoint | A population-level approach to suicide prevention.

28 May, 2021 | 08:12h | UTC

A Population-Level Approach to Suicide Prevention – JAMA

 


Google strikes a deal with hospital chain to use 32 million patient records to develop healthcare algorithms.

28 May, 2021 | 08:10h | UTC

Press release: HCA Healthcare Partners With Google Cloud to Accelerate Digital Transformation

Commentaries: Doctor Google will see you now! Privacy fears as tech giant ‘strikes deal’ with hospital chain to use 32 MILLION patient records to create algorithms that will guide healthcare workers’ decisions – The Daily Mail AND Google to use patient data to develop healthcare algorithms for hospital chain – The Verge

 


Management of patients after coronary artery bypass grafting surgery: a guide for primary care practitioners.

28 May, 2021 | 08:12h | UTC

Management of patients after coronary artery bypass grafting surgery: a guide for primary care practitioners – Canadian Medical Association Journal

 


Count the cost of disability caused by COVID-19 – “Focusing only on cases and deaths hides the pandemic’s lasting health burden on people, societies and economies”.

27 May, 2021 | 08:35h | UTC

Count the cost of disability caused by COVID-19 – Nature

 


RCT: 2 inactivated SARS-CoV-2 vaccines show efficacy of 72.8% and 78.1% on symptomatic COVID-19 infection in adults.

27 May, 2021 | 08:38h | UTC

Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial – JAMA

Commentary: China’s Sinopharm Publishes Awaited Covid Vaccine Study Details – Bloomberg

 

Commentary on Twitter (thread – click for more)

https://twitter.com/hildabast/status/1397678056270012419

 


Systematic review of 45 studies including 9751 participants, most of which were hospitalized, found 73% had at least 1 persistent symptom for weeks after Covid-19.

27 May, 2021 | 08:37h | UTC

Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review – JAMA Network Open

Commentary: Seven out of ten hospitalized COVID-19 patients will have long-haul symptoms – MedicalXpress

 


Can people vaccinated against COVID-19 still spread the coronavirus? – “Preliminary evidence seems to suggest the COVID-19 vaccines make it less likely someone who’s vaccinated will transmit the coronavirus”.

27 May, 2021 | 08:27h | UTC

Can people vaccinated against COVID-19 still spread the coronavirus? – The Conversation

Related: Indirect Protection by Reducing Transmission: Ending the Pandemic with SARS-CoV-2 Vaccination – “Tell the hesitant: the vaccines protect both you and protect others — a lot!”

 


[Preprint] More data showing a single-dose SARS-CoV-2 mRNA vaccine may be enough in individuals with previous COVID-19.

27 May, 2021 | 08:31h | UTC

Single-dose SARS-CoV-2 vaccine in a prospective cohort of COVID-19 patients – medRxiv

See also: SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors – EClinicalMedicine

Related: Another study shows a single dose of mRNA vaccine may be enough for patients with previous Covid-19

 

Commentaries on Twitter

 


COVID Morbidity – The emerging burden of long COVID is significant, and needs to be considered when evaluating the risk vs. benefit of pandemic measures.

27 May, 2021 | 08:34h | UTC

COVID Morbidity – Science-Based Medicine

 


Opinion | Rich countries cornered COVID-19 vaccine doses. Four strategies to right a ‘scandalous inequity’.

27 May, 2021 | 08:29h | UTC

Rich countries cornered COVID-19 vaccine doses. Four strategies to right a ‘scandalous inequity’ – Science (a few articles per month are free)

 

Commentary on Twitter

 


Moderna says its Covid vaccine is 100% effective in teens, plans to seek FDA OK in early June.

27 May, 2021 | 08:25h | UTC

Moderna says its Covid vaccine is 100% effective in teens, plans to seek FDA OK in early June – CNBC

 

Commentary on Twitter

 


RCT: Among patients with prosthetic joint infection, antibiotic therapy for 6 weeks was NOT shown to be noninferior to antibiotic therapy for 12 weeks and resulted in a higher percentage of patients with unfavorable outcomes.

27 May, 2021 | 08:20h | UTC

Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection – New England Journal of Medicine (link to abstract – $ for full-text)

 


Study suggests it is safe to discontinue antiseizure medication for most neonates with acute symptomatic seizures prior to discharge from the hospital.

27 May, 2021 | 08:14h | UTC

Safety of Early Discontinuation of Antiseizure Medication After Acute Symptomatic Neonatal Seizures – JAMA Neurology (free for a limited period)

Editorial: Discontinuing Antiseizure Medication in Neonates With Acute Symptomatic Seizures—Primum non nocere – JAMA Neurology (free for a limited period)

Commentaries: Stopping Antiseizure Medication After Acute Symptomatic Neonatal Seizures Is Found to Be Safe – Neurology Today AND Babies with Seizures May Be Overmedicated – Michigan Medicine

 

Commentary on Twitter

 


RCT: First-attempt intubation success is increased with the use an endotracheal tube + stylet vs. an endotracheal tube alone.

27 May, 2021 | 08:16h | UTC

Effect of the use of an endotracheal tube and stylet versus an endotracheal tube alone on first-attempt intubation success: a multicentre, randomised clinical trial in 999 patients – Intensive Care Medicine

 

Commentary on Twitter

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.